Iran Deal Clears Hormuz Tail Risk; Fed Independence Ruling Reduces Policy
Uncertainty; LLY Gains FDA Manufacturing Advantage
A US-Iran ceasefire deal halting Hormuz attacks drove a broad risk-on rally (SPY +1.65%, QQQ +2.49%) as the geopolitical risk premium that overweighted caution in the prior session compressed sharply. The Supreme Court ruling protecting Fed Governor Lisa Cook from removal preserves monetary policy predictability. Eli Lilly's selection for the FDA manufacturing precheck initiative adds a supply-side catalyst to the portfolio's top holding one session after Medicare coverage confirmed the demand side. The book trims Microsoft — which underperformed a strong tape day, failing to build on its prior bounce — and raises Amazon on continued momentum recovery and Iran de-escalation tailwinds to AWS demand visibility.
Published Jun 30, 2026Open Market Journal5 min readAI-assisted research · methodologyNot investment advice
- Added to AMZN from 18% to 20%
- Trimmed MSFT from 17% to 15%
Iran Deal Clears Hormuz Tail Risk; Fed Ruling Preserves Rate Clarity; LLY Gets FDA Manufacturing Catalyst
Tuesday delivered three distinct macro developments that shift the portfolio's risk environment toward the constructive end of the spectrum — none dependent on the others, all reinforcing the same directional message: the acute risk premiums that demanded caution in the prior session have compressed.
The Iran Ceasefire: Geopolitical Tail Risk Removed
The headline of the session was confirmation of a US-Iran deal to halt attacks on Strait of Hormuz shipping, with WTI crude returning above $70 and fresh diplomatic talks scheduled for Tuesday in Qatar. Markets priced this swiftly: SPY gained +1.65%, QQQ +2.49%, and the VIX fell from 18.41 to 17.65 as the probability of an acute supply disruption scenario was repriced lower.
For this portfolio, the most direct implication is the IWM position. Domestically-oriented small-cap businesses were the most exposed segment to a sustained Hormuz closure — energy and input cost inflation without the global procurement scale to hedge. That tail risk is now off the table at current probability. IWM holds at 10%; the thesis strengthens without requiring a position increase, because the Iran scenario was never the primary reason to own small-cap momentum — it was the primary risk to monitor against it.
Broader risk-on conditions benefited the growth-biased portfolio construction. Technology (XLK +2.37%), industrials (XLI +0.86%), and financials (XLF +0.28%) all gained, consistent with a market repricing geopolitical risk out of cyclical and growth names.
The Fed Independence Ruling: Monetary Policy Uncertainty Compressed
The Supreme Court ruled that President Trump cannot immediately remove Federal Reserve Governor Lisa Cook, establishing a legal barrier to politically driven interference with the rate-setting body. This is a meaningful de-risking event for the rate path. The tail scenario — where abrupt political pressure forced the Fed toward premature rate cuts, compressing NII margins for JPM and destabilizing the higher-for-longer framework underpinning financial sector earnings — has had its probability reduced.
For JPM specifically, the $50 billion buyback authorization remains the primary thesis anchor, but its value is compounded by a predictable rate environment. Management's capital deployment confidence is rational only if the interest rate backdrop is not subject to executive-branch disruption; today's ruling increases that confidence. JPM +0.10% tracked the financials sector (XLF +0.28%) on a day when the primary macro risk to the book was resolved.
LLY: FDA Manufacturing Precheck Adds Supply-Side Catalyst
Eli Lilly was named among the first companies selected for the FDA's new initiative to speed review of manufacturing facilities — a direct operational catalyst for the top position. The primary structural risk to the GLP-1 demand story — Medicare coverage confirmed in the prior session — has always been the supply side: manufacturing capacity to deliver tirzepatide at the volume implied by a newly Medicare-eligible population of tens of millions of seniors. The FDA precheck program accelerates regulatory review of new facilities, giving LLY a structured pathway to expand production ahead of competitors still building initial capacity.
LLY gained +1.81% in a session where the prior catalyst had already generated a +7.13% move. The market's continued positive response to incremental news rather than fading it signals genuine institutional accumulation rather than fast-money positioning. The 60-day momentum of +20.59% is not only the strongest in the candidate universe — it is the clearest evidence of a structural regime change that the market is still pricing in progressively.
The position holds at 25%. A catalyst of this quality on the top holding warrants no reduction.
Portfolio Adjustments: MSFT Trimmed to 15%, AMZN Raised to 20%
Two modifications reflect the day's evidence:
Microsoft is trimmed from 17% to 15%. MSFT declined -1.18% in a session where QQQ gained +2.49% and technology broadly rallied +2.37%. A name that underperforms a strong tape day — immediately following a +5.71% recovery session — has not established the momentum confirmation needed to reverse its negative 20-day (-6.93%) and 60-day (-9.16%) readings. The Azure cloud growth and Copilot enterprise thesis is unchanged. Pershing Square's 15.3% book weight remains the institutional anchor. The reduction is a momentum signal, not a thesis exit. If MSFT begins consistently participating on strong tape days, the position is rebuilt.
Amazon is raised from 18% to 20%. AMZN delivered +3.20% today — its second strong consecutive session — and the 20-day momentum has recovered from -4.65% to -0.97%, approaching the flat line. The Iran ceasefire is a direct tailwind for AWS: enterprises with Middle East exposure that have been deferring long-cycle cloud infrastructure commitments face one fewer reason to delay. Hyperscaler demand sits at the center of the AI infrastructure buildout, and geopolitical stability reduces the discount applied to multi-year contractual revenue. Pershing Square at 17.4% and Bridgewater at 4.1% are the institutional floor. The weight increase from 18% to 20% reflects recovery-in-progress; the 60-day momentum of -4.67% keeps this from a more aggressive addition.
What Could Break the Thesis
Three watchpoints define the week:
Iran ceasefire durability. Tuesday's Qatar talks are the first operational test of whether the deal holds. A breakdown re-introduces Hormuz risk premium across energy, industrials, and IWM — and would warrant immediate reassessment of the risk-on positioning established today.
Friday's jobs report. Prediction markets on Kalshi expect the headline number to disappoint Wall Street's forecast. A weak payroll print is rate-cut positive for duration but raises concerns about small-cap earnings sustainability (IWM) and discretionary consumer demand (AMZN retail). LLY — driven by structural healthcare demand rather than the economic cycle — is the most insulated position. JPM's NII trajectory would benefit modestly from a delayed-cut confirmation if a weak print does not materially shift Fed signaling.
MSFT momentum confirmation. The trimmed position at 15% is rebuilt if MSFT demonstrates sustained participation on strong tape days in the sessions ahead. The next week is the observable confirmation window.
VIX at 17.65 versus 18.41 the prior session confirms that markets are treating the Iran resolution as genuine, not a temporary pause. The risk environment today is the most constructive the portfolio has faced since the Hormuz shock was introduced, and the construction reflects that.
Positioning
2 of 6 lines changed · weights sum to 100% · published Jun 30, 2026- AMZN20%was 18%
Amazon is raised from 18% to 20%. The position delivered +3.20% in today's session — its second strong consecutive day — and the 20-day momentum has recovered from -4.65% to -0.97%, approaching the flat line. The Iran ceasefire is a direct tailwind for AWS: enterprises with Middle East supply chain exposure that have been deferring long-cycle cloud commitments face one fewer reason to delay, and geopolitical stability reduces the discount applied to multi-year contractual revenue. Pershing Square at 17.4% and Bridgewater at 4.1% of their respective books remain the institutional floor. The weight increase from 18% to 20% reflects recovery-in-progress rather than full thesis confirmation — the 60-day momentum of -4.67% remains negative and continued follow-through is required before restoring the position to prior highs.
- MSFT15%was 17%
Microsoft is trimmed from 17% to 15%. MSFT declined -1.18% in a session where QQQ gained +2.49% and technology broadly (XLK +2.37%) rallied. A name that underperforms a strong tape day — one session after a +5.71% recovery — has not established the durable follow-through needed to reverse its negative 20-day (-6.93%) and 60-day (-9.16%) momentum. The Azure cloud growth and Copilot enterprise monetization thesis is unchanged, and Pershing Square's 15.3% book weight remains the primary institutional validation. The trim is a momentum signal, not a thesis exit — the freed weight moves to AMZN where recovery is demonstrably in progress. If MSFT begins consistently participating on strong tape days in the sessions ahead, the weight is rebuilt.
- LLY25%unchanged
Eli Lilly holds at 25% on back-to-back structural catalysts: Medicare coverage of GLP-1 drugs for seniors confirmed last session, and today's FDA manufacturing precheck selection directly de-risks the supply bottleneck that was the primary execution risk to the demand expansion. The program accelerates regulatory review of new manufacturing facilities, extending LLY's structural runway advantage over competitors attempting to build comparable capacity at scale. LLY gained +1.81% in a session where the prior catalyst had already generated +7.13%, signaling the market reads today's news as incremental reinforcement rather than diminishing returns. The 20-day momentum of +9.03% and 60-day of +20.59% remain the strongest in the candidate universe by a wide margin. No reduction is warranted when the top holding is generating new catalysts that directly address its primary operational risk.
- JPM20%unchanged
JPMorgan holds at 20%. The $50 billion share buyback authorization remains the anchor catalyst. Today's Supreme Court ruling protecting Fed Governor Lisa Cook is a second-order positive: it preserves the predictability of the rate-setting body that determines NII trajectory. A politically disrupted Fed forced toward premature rate cuts would compress NII headroom; the ruling maintains the higher-for-longer baseline that supports JPM's net interest margin. Management's confidence in the capital deployment program is rational only if the interest rate backdrop remains stable — today's ruling increases that confidence. JPM +0.10% held in line with the financials sector (XLF +0.28%) on a day when the primary macro risk to the book was resolved. The 20-day momentum of +3.08% and 60-day of +6.08% remain consistently positive.
- NVDA10%unchanged
NVIDIA holds at 10%. The +1.27% session is modest participation in a strong tape — better than yesterday's -1.64% but still meaningfully below QQQ's +2.49% recovery. The Micron post-earnings rally nearly fully reversing is a sector-level signal that initial AI infrastructure demand excitement may be running into near-term positioning exhaustion in semiconductors broadly. NVDA's 20-day (-5.79%) and 60-day (-5.44%) momentum remain the weakest in the portfolio. The secular AI infrastructure demand thesis — Blackwell GPU deployments, HBM3e supply scarcity, hyperscaler capex — is intact and Bridgewater holds NVDA at 3.7% of their book. The position is maintained as a placeholder for when momentum confirms a genuine reversal, not exited on secular thesis grounds.
- IWM10%unchanged
The Russell 2000 ETF holds at 10%. The Iran ceasefire directly strengthens the thesis: the Hormuz disruption scenario that threatened inflation in domestically-oriented small-cap supply chains is now off the table at current probability levels. IWM -0.29% on a day when the primary headwind to the position was resolved is modest underperformance likely reflecting investors waiting for Qatar talk confirmation before fully pricing out the risk. The 20-day momentum of +2.45% and 60-day of +6.31% remain the second-strongest sustained trend in the portfolio after LLY. IWM is the first position to reduce if the Iran deal collapses or if Friday's jobs report drives credit conditions tightening that disproportionately pressures small-cap earnings.
Sources and evidence
- Eli Lilly, Regeneron among first companies selected for FDA initiative to speed review of new manufacturing facilities · CNBC
- Supreme Court rulings on Fed, FTC: What they mean for consumers · CNBC
- Salesforce is on an AI buying spree, but Wall Street still has its doubts · CNBC
- Oil prices rise as U.S. and Iran reach deal to halt attacks, U.S. oil above $70 per barrel again · CNBC
- Micron's monster post-earnings rally is almost gone. Traders divided on where it goes next · CNBC
- Supreme Court rules Trump cannot fire Fed Governor Lisa Cook for now · CNBC
- Putin’s fuel shortage admission signals growing strain on Russia’s energy infrastructure · CNBC
- Op-ed: If you think China needs to dethrone U.S. dollar, you don't understand how it is waging global currency war · CNBC
- Kalshi traders expect this week's jobs report will disappoint Wall Street outlook · CNBC
- This insurance stock is on an impressive run. How to ride the momentum with less risk · CNBC
- Oil prices near pre-war levels — but persistent supply risks could spark a rebound, analysts warn · CNBC
- Trump says U.S. and Iran to hold fresh talks in Qatar on Tuesday following weekend clashes · CNBC